Defects in initiating or executing cell death programs are responsible for cancer chemoresistance. The growing understanding of apoptotic programs suggests that compounds simultaneously inhibiting multiple signaling pathways might provide a better therapeutic outcome than that of individual inhibitors.
Turrini, E., Ferruzzi, L., Fimognari, C. (2014). Natural compounds to overcome cancer chemoresistance: Toxicological and clinical issues. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 10(12), 1677-1690 [10.1517/17425255.2014.972933].
Natural compounds to overcome cancer chemoresistance: Toxicological and clinical issues
TURRINI, ELEONORA;FERRUZZI, LORENZO;FIMOGNARI, CARMELA
2014
Abstract
Defects in initiating or executing cell death programs are responsible for cancer chemoresistance. The growing understanding of apoptotic programs suggests that compounds simultaneously inhibiting multiple signaling pathways might provide a better therapeutic outcome than that of individual inhibitors.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
